CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Brad Gray

Senior Vice President, Strategic Development; formerly CEO, NanoString Technologies, Danaher Corporation

Search every verified Brad Gray interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Brad Gray, formerly CEO of NanoString Technologies and now Senior Vice President of Strategic Development at Danaher, discussed the company's trajectory and the spatial biology market in a June 2021 podcast appearance. He described NanoString's early struggles with commercialization after its founding as a spin-off from the Institute for Systems Biology, and noted that he was hired in 2010 to lead the company into broader markets, including cancer diagnostics. Gray recounted lessons learned from relying on pharmaceutical partners for cash, and explained his rationale for acquiring Encounter, which he characterized as providing a diagnostic platform aligned with NanoString's research tools. Gray estimated the total addressable market for spatial biology at $16 billion, comprising approximately $8 billion annually in research applications and $8 billion in diagnostics. He compared spatial biology to prior revolutions in genomics, suggesting that NanoString could play a role analogous to Illumina in bulk genomics or 10x Genomics in single-cell genomics. He also used an analogy describing traditional bulk genomics as blending tissue into a smoothie, in contrast to spatial methods that preserve tissue context.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →